Vascular Function Improvements Derived From Exercise Are Not Sex-Dependent
1. The exercise training prevented increases in total cholesterol and LDL cholesterol which were observed in the non-exercise group and ...
Tag: LDL
Treat-to-target approach non-inferior to high-dose statin therapy in patients with coronary artery disease
1. Patients who received statin therapy using a treat-to-target approach (targeting LDL-cholesterol of 50-70mg/dL) did not have worse cardiovascular outcomes ...
![Ivabradine ineffective in stable coronary artery disease [SIGNIFY trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/800px-RCA_atherosclerosis-350x250.jpg)
Olpasiran significantly reduces lipoprotein(a) levels in patients with cardiovascular disease
1. Olpasiran significantly and substantially reduced lipoprotein(a) concentration in patients with atherosclerotic cardiovascular disease compared to placebo. 2. Olpasiran reduced ...
Combination-drug therapy and earlier detection recommended to improve outcomes in heterozygous familial hypercholesterolemia
1. A significantly greater proportion of patients receiving 2-3 lipid lowering medications achieved LDL-cholesterol targets compared to those receiving monotherapy. ...
#VisualAbstract: Improved sleep quality reduced cardio-metabolic risk factors
1. In this study, improved sleep quality was associated with significantly decreased systolic blood pressure and increased high-density lipoprotein levels ...
Elevated LDL cholesterol associated with increased risk of myocardial infarction and ASCVD in individuals aged 70-100 years
1. In individuals aged 70-100 years, there was a significantly increased risk of myocardial infarction and atherosclerotic cardiovascular disease for ...
LDL cholesterol-lowering therapies reduce the risk of cardiovascular events in older patients
1. In patients aged ≥75 years, LDL cholesterol-lowering therapies reduced the risk for major vascular events, including cardiovascular death, myocardial ...
#VisualAbstract: Evinacumab demonstrates efficacy for homozygous familial hypercholesterolemia
1. Evinacumab significantly lowered low-density lipoprotein (LDL) cholesterol levels in patients with homozygous familial hypercholesterolemia. 2. Patients receiving evinacumab did ...
Evinacumab lowers LDL in homozygous familial hypercholesterolemia patients
1. Evinacumab significantly lowered low-density lipoprotein (LDL) cholesterol levels in patients with homozygous familial hypercholesterolemia. 2. Patients receiving evinacumab did ...
Lower LDL associated with regression of pre-existing atherosclerotic lesions but not carotid plaque incidence
1. Targeting a lower LDL does not impact carotid plaque incidence but does increase the rate of regression of pre-existing ...